Hims Stock Tumbles As FDA Targets Its Discounted Weight-Loss Drugs
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug’s ingredients and referring the company to the…
Read More...
Read More...